MFDS — authorised 29 May 1997
- Marketing authorisation holder: PROSTRAKAN INC
- Status: likely_approved
🇰🇷 Fareston in South Korea
MFDS authorised Fareston on 29 May 1997
Marketing authorisation
Fareston in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Fareston approved in South Korea?
Yes. MFDS authorised it on 29 May 1997.
Who is the marketing authorisation holder for Fareston in South Korea?
PROSTRAKAN INC holds the South Korean marketing authorisation.